AVNT vs. ALB, EMN, HXL, ROG, PCT, ASIX, TSE, DNMR, DOW, and DD
Should you be buying Avient stock or one of its competitors? The main competitors of Avient include Albemarle (ALB), Eastman Chemical (EMN), Hexcel (HXL), Rogers (ROG), PureCycle Technologies (PCT), AdvanSix (ASIX), Trinseo (TSE), Danimer Scientific (DNMR), DOW (DOW), and DuPont de Nemours (DD). These companies are all part of the "plastics materials & resins" industry.
Avient (NYSE:AVNT) and Albemarle (NYSE:ALB) are both basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, community ranking, earnings, risk and institutional ownership.
Albemarle has higher revenue and earnings than Avient. Avient is trading at a lower price-to-earnings ratio than Albemarle, indicating that it is currently the more affordable of the two stocks.
Avient has a beta of 1.53, indicating that its share price is 53% more volatile than the S&P 500. Comparatively, Albemarle has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500.
Avient pays an annual dividend of $1.03 per share and has a dividend yield of 2.3%. Albemarle pays an annual dividend of $1.60 per share and has a dividend yield of 1.3%. Avient pays out 89.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Albemarle pays out 58.2% of its earnings in the form of a dividend.
95.5% of Avient shares are held by institutional investors. Comparatively, 92.9% of Albemarle shares are held by institutional investors. 1.9% of Avient shares are held by company insiders. Comparatively, 0.4% of Albemarle shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
In the previous week, Albemarle had 5 more articles in the media than Avient. MarketBeat recorded 8 mentions for Albemarle and 3 mentions for Avient. Avient's average media sentiment score of 1.48 beat Albemarle's score of 0.40 indicating that Avient is being referred to more favorably in the media.
Avient currently has a consensus target price of $46.20, suggesting a potential upside of 3.40%. Albemarle has a consensus target price of $165.16, suggesting a potential upside of 34.72%. Given Albemarle's higher probable upside, analysts plainly believe Albemarle is more favorable than Avient.
Albemarle has a net margin of 4.02% compared to Avient's net margin of 3.37%. Albemarle's return on equity of 14.53% beat Avient's return on equity.
Albemarle received 736 more outperform votes than Avient when rated by MarketBeat users. Likewise, 63.39% of users gave Albemarle an outperform vote while only 45.61% of users gave Avient an outperform vote.
Summary
Albemarle beats Avient on 15 of the 20 factors compared between the two stocks.
Get Avient News Delivered to You Automatically
Sign up to receive the latest news and ratings for AVNT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AVNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
